I'm at Liverpool University <a href="https://prismarte.com.br/glucophage-xr ... -jiiv">glucophage xr opinie forum</a> PRADAXA is currently approved by the FDA to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), and was the first oral anticoagulant approved by the FDA in more than 50 years for this indication.